IP Library Granted Patent US 8,703,900
Granted Patent B2
US 8,703,900 · App. 13/701,581 · Granted Apr 22, 2014

Processes for producing caprolactam and derivatives thereof from fermentation broths containing diammonium adipate, monoammonium adipate and/or adipic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,900
App. No.
13/701,581
Granted
Apr 22, 2014
Kind
B2
Abstract

Processes for making caprolactam (CL) from monoammonium adipate (MAA) and/or adipic acid (AA) obtained from a clarified diammonium adipate-containing (DAA-containing) fermentation broth or MAA-containing fermentation broth and converting the MAA or AA to the CL with hydrogen in the presence of a catalyst at selected temperatures and pressures.

Claims (52)

1. A process for producing CL from a clarified DAA-containing fermentation broth, comprising:

(a) distilling the broth to form an overhead that comprises water and ammonia, and a liquid bottoms that comprises MAA, at least some DAA, and at least about 20 wt % water;

(b) cooling and/or evaporating the bottoms, and optionally adding an antisolvent to the bottoms, to attain a temperature and composition sufficient to cause the bottoms to separate into a DAA-containing liquid portion and a MAA-containing solid portion that is substantially free of DAA;

(c) separating the solid portion from the liquid portion;

(d) recovering the solid portion; and

(e) contacting at least a portion of the solid portion with hydrogen, optionally in the presence of a solvent, in the presence of to hydrogenation catalyst and, optionally an ammonia source, at a temperature of about 25° C. to about 500° C. and a pressure of about 0.5 to about 40 MPa to produce the CL.

2. A process for producing CL from a DAA-containing fermentation broth, comprising:

(a) distilling the broth to form a first overhead that includes water and ammonia, and a first liquid bottoms that includes MAA, at least some DAA, and at least about 20 wt % water;

(b) cooling and/or evaporating the bottoms, and optionally adding an antisolvent to the bottoms, to attain a temperature and composition sufficient to cause the bottoms to separate into a DAA-containing liquid portion and a MAA-containing solid portion that is substantially free of DAA;

(c) separating the solid portion from the liquid portion;

(d) recovering the solid portion;

(e) dissolving the solid portion in water to produce an aqueous MAA solution;

(f) distilling the aqueous MAA solution at a temperature and pressure sufficient to form a second overhead that includes water and ammonia, and a second bottoms that includes a major portion of AA, a minor portion of MAA, and water;

(g) cooling and/or evaporating the second bottoms to cause the second bottoms to separate into a second liquid portion in contact with a second solid portion that preferably consists essentially of AA and is substantially free of MAA;

(h) separating the second solid portion from the second liquid portion;

(i) recovering the second solid portion; and

(j) contacting at least a portion of the solid portion with hydrogen, optionally in the presence of a solvent, in the presence of a hydrogenation catalyst and, an ammonia source, at a temperature of about 25° C. to about 500° C. and a pressure of about 0.5 to about 40 MPa to produce the CL.

3. A process for producing CL from a clarified MAA-containing fermentation broth comprising:

(a) optionally, adding MAA, DAA, AA, NH 3 , and/or NH 4 + to the broth to preferably maintain the pH of the broth below 6;

(b) distilling the broth to form an overhead that includes water and optionally ammonia, and a liquid bottoms that includes MAA, at least some DAA, and at least about 20 wt % water;

(c) cooling and/or evaporating the bottoms, and optionally adding an antisolvent to the bottoms, to attain a temperature and composition sufficient to cause the bottoms to separate into a DAA-containing liquid portion and a MAA-containing solid portion that is substantially free of DAA;

(d) separating the solid portion from the liquid portion;

(e) recovering the solid portion; and

(f) contacting at least a portion of the solid portion with hydrogen, optionally in the presence of a solvent, in the presence of a hydrogenation catalyst and, optionally an ammonia source, at a temperature of about 25° C. to about 500° C. and a pressure of about 0.5 to about 40 MPa to produce the CL.

4. A process for producing CL from a clarified MAA-containing fermentation broth comprising:

(a) optionally, adding MAA, DAA, AA, NH 3 , and/or NH 4 + to the broth to preferably maintain the pH of the broth below 6;

(b) distilling the broth to form an overhead that includes water and optionally ammonia, and a liquid bottoms that includes MAA, at least some DAA, and at least about 20 wt % water;

(c) cooling and/or evaporating the bottoms, and optionally adding an antisolvent to the bottoms, to attain a temperature and composition sufficient to cause the bottoms to separate into a DAA-containing liquid portion and a MAA-containing solid portion that is substantially free of DAA;

(d) separating the solid portion from the liquid portion;

(e) recovering the solid portion;

(f) dissolving the solid portion in water to produce an aqueous MAA solution;

(g) distilling the aqueous MAA solution at a temperature and pressure sufficient to form a second overhead that includes water and ammonia, and a second bottoms that includes a major portion of AA, a minor portion of MAA, and water;

(h) cooling and/or evaporating the second bottoms to cause the second bottoms to separate into a second liquid portion in contact with a second solid portion that preferably consists essentially of AA and is substantially free of MAA;

(i) separating the second solid portion from the second liquid portion;

(j) recovering the second solid portion; and

(k) contacting at least a portion of the solid portion with hydrogen, optionally in the presence of a solvent, in the presence of a hydrogenation catalyst and, an ammonia source, at a temperature of about 25° C. to about 500° C. and a pressure of about 0.5 to about 40 MPa to produce the CL.

5. The process of claim 1 , wherein producing CL comprises dehydrating the solid portion to form an amide of AA followed by hydrogenation of the amide to form CL.

6. The process of claim 2 , wherein producing the CL comprises dehydrating the second solid portion in the presence of an ammonia source to produce an amide of AA followed by hydrogenation of the amide to for CL.

7. The process of any of claim 1 , further comprising converting the CL to NYLON 6.

8. The process of claim 1 , wherein the fermentation broth is obtained by fermenting a carbon source in the presence of a microorganism selected from the group consisting of Candida tropicalis (Castellani) Berkhout, anamorph strain OH23 having ATCC accession number 24887; E. coli strain AB2834/pKD136/pKD8.243A/pKD8.292: having ATCC accession number 69875; E. coli cosmid clone 5B12 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1, E. coli cosmid clone 5F5 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; E. coli cosmid clone 8F6 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; E. coli cosmid clone 14D7 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; and Verdezyne Yeast.

9. The process of claim 1 , wherein distillation is carried out in the presence of an ammonia separating solvent which is at least one selected from the group consisting of diglyme, triglyme, tetraglyme, sulfoxides, amides, sulfones, polyethyleneglycol (PEG), butoxytriglycol, N-methylpyrolidone (NMP), ethers, and methyl ethyl ketone (MEK) or in the presence of a water azeotroping solvent which is at least one selected from the group consisting of toluene, xylene, methylcyclohexane, methyl isobutyl ketone, hexane, cyclohexane and heptane.

10. The process of claim 3 , wherein producing CL comprises dehydrating the solid portion to form an amide of AA followed by hydrogenation of the amide to form CL.

11. The process of claim 4 , wherein producing the CL comprises dehydrating the second solid portion in the presence of an ammonia source to produce an amide of AA followed by hydrogenation of the amide to form CL.

12. The process of claim 2 , further comprising converting the CL to NYLON 6.

13. The process of claim 3 , further comprising converting the CL to NYLON 6.

14. The process of claim 4 , further comprising converting the CL to NYLON 6.

15. The process of claim 2 , wherein the fermentation broth is obtained by fermenting a carbon source in the presence of a microorganism selected from the group consisting of Candida tropicalis (Castellani) Berkhout, anamorph strain OH23 having ATCC accession number 24887; E. coli strain AB2834/pKD136/pKD8.243A/pKD8.292 having ATCC accession number 69875 ; E. coli cosmid clone 5B12 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1, E. coli cosmid clone 5F5 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1 ; E. coli cosmid clone 8F6 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; E. coli cosmid clone 14D7 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; and Verdezyne Yeast.

16. The process of claim 3 , wherein the fermentation broth is obtained by fermenting a carbon source in the presence of a microorganism selected from the group consisting of Candida tropicalis (Castellani) Berkhout, anamorph strain OH23 having ATCC accession number 24887; E. coli strain AB2834/pKD136/pKD8.243A/pKD8.292 having ATCC accession number 69875; E. coli cosmid clone 5B12 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1, E. coli cosmid clone 5F5 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; E. coli cosmid done 8F6 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1 ; E. coli cosmid clone 14D7 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; and Verdezyne Yeast.

17. The process of claim 4 , wherein the fermentation broth is obtained by fermenting a carbon source in the presence of a microorganism selected from the group consisting of Candida tropicalis (Castellani) Berkhout, anamorph strain OH23 having ATCC accession number 24887 ; E. coil strain AB2834/pKD136/pKD8.243A/pKD8.292 having ATCC accession number 69875; E. coli cosmid clone 5B12 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1 , E. coli cosmid clone 5F5 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; E. coli cosmid clone 8F6 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; E. coli cosmid clone 14D7 comprising a vector expressing the cyclohexanone monoxygenase encoded by SEQ ID NO: 1; and Verdezyne Yeast.

18. The process of claim 2 , wherein distillation is carried out in the presence of an ammonia separating solvent which is at least one selected from the group consisting of diglyme, triglyme, tetraglyme, sulfoxides, amides, sulfones, polyethyleneglycol (PEG), butoxytriglycol, N-methylpyrolidone (NMP), ethers, and methyl ethyl ketone (MEK) or in the presence of a water azeotroping solvent which is at least one selected from the group consisting of toluene, xylene, methylcyclohexane, methyl isobutyl ketone, hexane, cyclohexane and heptane.

19. The process of claim 3 , wherein distillation is carried out in the presence of an ammonia separating solvent which is at least one selected from the group consisting of diglyme, triglyme, tetraglyme, sulfoxides, amides, sulfones, polyethyleneglycol (PEG), butoxytriglycol, N-methylpyrolidone (NMP), ethers, and methyl ethyl ketone (MEK) or in the presence of a water azeotroping solvent which is at least one selected from the group consisting of toluene, xylene, methylcyclohexane, methyl isobutyl ketone, hexane, cyclohexane and heptane.

20. The process of claim 4 , wherein distillation is carried out in the presence of an ammonia separating solvent which is at least one selected from the group consisting of diglyme, triglyme, tetraglyme, sulfoxides, amides, sulfones, polyethyleneglycol (PEG), butoxytriglycol, N-methylpyrolidone (NMP), ethers, and methyl ethyl ketone (MEK) or in the presence of a water azeotroping solvent which is at least one selected from the group consisting of toluene, xylene, methylcyclohexane, methyl isobutyl ketone, hexane, cyclohexane and heptane.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2020
From: BIOAMBER INC.
To: LCY BIOSCIENCES INC.
Reel/Frame 054060/0253 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 16, 2017
From: BIOAMBER INC.
To: MITSUI & CO., LTD.
Reel/Frame 043576/0072 →
SECURITY INTEREST Recorded Jan 26, 2015
From: BIOAMBER INC.
To: OBSIDIAN AGENCY SERVICES, INC.
Reel/Frame 034816/0968 →
SECURITY AGREEMENT Recorded Jan 15, 2014
From: BIOAMBER INC.
To: HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
Reel/Frame 032020/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2013
From: BIOAMBER S.A.S.
To: BIOAMBER INC.
Reel/Frame 030511/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: FRUCHEY, OLAN S.; KEEN, BRIAN T.; ALBIN, BROOKE A.; CLINTON, NYE A.; DOMBEK, BERNARD D.
To: MID-ATLANTIC TECHNOLOGY RESEARCH & INNOVATION CENTRE (MATRIC)
Reel/Frame 029501/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: MID-ATLANTIC TECHNOLOGY RESEARCH & INNOVATION CENTRE (MATRIC)
To: BIOAMBER S.A.S.
Reel/Frame 029501/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2012
From: MANZER, LEO E.; DUNUWILA, DILUM
To: BIOAMBER S.A.S.
Reel/Frame 029501/0176 →